Johnson & Johnson vs Thermo Fisher Scientific Inc — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
TMO
Consensus analyst target of $620.13 is 32% above current price.
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $620.13 (+32.2%)
24 analysts
Fundamentals
JNJ
TMO
26.3×
Trailing P/E
25.8×
17.9×
Forward P/E
17.1×
21.8%
Profit Margin
15.2%
68.0%
Gross Margin
40.9%
26.4%
ROE
13.5%
9.9%
Revenue Growth
6.2%
-52.9%
Earnings Growth
11.3%
0.33
Beta
0.97
—
Price / Book
—
$546.9B
Market Cap
$174.4B
$146 – $252
52-Week Range
$385 – $644
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →